Literature DB >> 20555262

Evaluation of patients with suspected coronary artery disease.

Daniel S Menees1, Eric R Bates.   

Abstract

Coronary artery disease affects millions of Americans and is a major cause of global morbidity and mortality. Detection and optimal treatment strategies are needed to reduce the clinical and economic burden of this disease. Chest pain history, risk factor profile, and noninvasive stress test results are used for clinical risk stratification. In high-risk patients, coronary angiography is the standard for anatomic diagnosis and additional risk stratification. All patients with coronary artery disease should be treated with optimal medical therapy. Patients with uncontrolled symptoms or high risk for adverse outcomes benefit from coronary artery revascularization with percutaneous coronary intervention or coronary artery bypass graft surgery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20555262     DOI: 10.1097/MCA.0b013e32833bfdf7

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  4 in total

1.  Association between Lp-PLA2 and coronary heart disease in Chinese patients.

Authors:  Li Yang; Yin Liu; Shufeng Wang; Ting Liu; Hongliang Cong
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

2.  Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease.

Authors:  Yuhong Zhao; Ran Peng; Wang Zhao; Qiong Liu; Yuan Guo; Shuiping Zhao; Danyan Xu
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

3.  Antiobesity, Regulation of Lipid Metabolism, and Attenuation of Liver Oxidative Stress Effects of Hydroxy-α-sanshool Isolated from Zanthoxylum bungeanum on High-Fat Diet-Induced Hyperlipidemic Rats.

Authors:  Li Wang; Wenxiang Fan; Mengmeng Zhang; Qing Zhang; Lin Li; Jiaolong Wang; Lei Zhu; Daneng Wei; Wei Peng; Chunjie Wu
Journal:  Oxid Med Cell Longev       Date:  2019-08-27       Impact factor: 6.543

4.  Associations of myeloperoxidase, interleukin-17A and heparin-binding EGF-like growth factor levels with in-stent restenosis after percutaneous coronary intervention: a single-centre case-control study in China.

Authors:  Hua Jiang; Hongmei Zhang; Ying Yang; Xuezhou Yang
Journal:  BMJ Open       Date:  2020-11-06       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.